Review article · 2024 · Open access
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Drug Design Development and Therapy, Volume 18, 1469–1495 · Published 1 May 2024 · DOI 10.2147/dddt.s447496
In brief
“Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs” is a 2024 review article by Yifan Liu and 10 co-authors, published in Drug Design Development and Therapy. OpenAlex counts 427 citations as of 15 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY-NC licence: the full text is free to read at Drug Design Development and Therapy.
- Citations
- 427
- Most cited in
- 2026 (222)
- Field-weighted impact
- 14.09
- References
- 180
- Authors
- 11
Abstract
This manuscript offers a comprehensive overview of nanotechnology's impact on the solubility and bioavailability of poorly soluble drugs, with a focus on BCS Class II and IV drugs. We explore various nanoscale drug delivery systems (NDDSs), including lipid-based, polymer-based, nanoemulsions, nanogels, and inorganic carriers. These systems offer improved drug efficacy, targeting, and reduced side effects. Emphasizing the crucial role of nanoparticle size and surface modifications, the review discusses the advancements in NDDSs for enhanced therapeutic outcomes. Challenges such as production cost and safety are acknowledged, yet the potential of NDDSs in transforming drug delivery methods is highlighted. This contribution underscores the importance of nanotechnology in pharmaceutical engineering, suggesting it as a significant advancement for medical applications and patient care.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., & Ma, Y. (2024). Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs. Drug Design Development and Therapy, Volume 18, 1469–1495. https://doi.org/10.2147/dddt.s447496
MLA 9
Liu, Yifan, et al. “Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.” Drug Design Development and Therapy, vol. Volume 18, 2024, pp. 1469–1495. https://doi.org/10.2147/dddt.s447496.
Chicago
Liu, Yifan, Yushan Liang, Jing Yuhong, Peng Xin, Jia Han, Yongle Du, Xinru Yu, et al. 2024. “Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs.” Drug Design Development and Therapy Volume 18: 1469–1495. https://doi.org/10.2147/dddt.s447496.
Harvard
Liu, Y. et al. (2024) ‘Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs’, Drug Design Development and Therapy, Volume 18, pp. 1469–1495. doi:10.2147/dddt.s447496.
IEEE
Y. Liu et al., “Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs,” Drug Design Development and Therapy, vol. Volume 18, pp. 1469–1495, 2024, doi: 10.2147/dddt.s447496.
BibTeX
@article{liu2024advances,
title = {{Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs}},
author = {Liu, Yifan and Liang, Yushan and Yuhong, Jing and Xin, Peng and Han, Jia and Du, Yongle and Yu, Xinru and Zhu, Runhe and Zhang, Mingxun and Chen, Wen and Ma, Yingjie},
journal = {Drug Design Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {1469--1495},
doi = {10.2147/dddt.s447496},
url = {https://doi.org/10.2147/dddt.s447496}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 23 | |
| 2025 | 182 | |
| 2026 | 222 |
Its field-weighted citation impact is 14.09: it has been cited 14.09 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- nanotechnology
- poorly water-soluble drugs
- drug solubility enhancement
- bioavailability
- BCS class II drugs
- BCS class IV drugs
- nanoscale drug delivery systems
- lipid-based nanocarriers
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., & Ma, Y. (2024). Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs. Drug Design Development and Therapy, Volume 18, 1469–1495. https://doi.org/10.2147/dddt.s447496
How many times has this paper been cited?
427 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Drug Design Development and Therapy.
Who wrote this paper?
Yifan Liu, Yushan Liang, Jing Yuhong, Peng Xin, Jia Han, Yongle Du, Xinru Yu, Runhe Zhu, Mingxun Zhang, Wen Chen, Yingjie Ma.
What is the DOI of this paper?
10.2147/dddt.s447496. The permanent link is https://doi.org/10.2147/dddt.s447496.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.